Funding · Company
Alveus Therapeutics, Inc.
Philadelphia, PABiotech & Pharma
Alveus Therapeutics, Inc. of Philadelphia, PA has disclosed $57M across 1 Form D offering filed with the SEC on Jan 14, 2026.
$57M
Total disclosed
1
Form D offering
4
Open roles today
Hiring — 4 open roles as of Sep 23, 2026
Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$57M
Form D · Jan 14, 2026 ↗
Q1 2026
· target $111M
Filing details
HeadquartersPhiladelphia, PAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2023SEC CIK0002075856Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →